Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Alessandra Bracigliano
Observed names:
A Bracigliano,
A. Bracigliano,
Bracigliano, Alessandra,
alessandra bracigliano
Institution:
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"
Observed institutions:
Azienda Ospedaliera S.Giuseppe Moscati,
Federico II University Hospital,
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale",
University of Naples Federico II
ORCID:
0000-0002-5253-136X
Observed ORCID:
0000-0002-5253-136X
OpenAlex ID:
A5081315971
Liver iron excess in patients with hepatocellular carcinoma developed on non-alcoholic steato-hepatitis
2008
·
Paolo Sorrentino
, Salvatore D’Angelo
, et al.
·
Journal of Hepatology
·
197
Predicting Fibrosis Worsening in Obese Patients With NASH Through Parenchymal Fibronectin, HOMA-IR, and Hypertension
2009
·
Paolo Sorrentino
, Luigi Terracciano
, et al.
·
The American Journal of Gastroenterology
·
97
Malignant Sinonasal Tumors: Update on Histological and Clinical Management
2021
·
Alessandra Bracigliano
, Fabiana Tatangelo
, et al.
·
Current Oncology
·
80
PDF
Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors
2022
·
Sara Pusceddu
, Natalie Prinzi
, et al.
·
JAMA Network Open
·
66
PDF
Preservation of nutritional‐status in patients with refractory ascites due to hepatic cirrhosis who are undergoing repeated paracentesis
2011
·
Paolo Sorrentino
, Giuseppe Castaldo
, et al.
·
Journal of Gastroenterology and Hepatology
·
59
Oxidative stress and steatosis are cofactors of liver injury in primary biliary cirrhosis
2010
·
Paolo Sorrentino
, Luigi Terracciano
, et al.
·
Journal of Gastroenterology
·
59
Contrast-enhanced sonography versus biopsy for the differential diagnosis of thrombosis in hepatocellular carcinoma patients
2009
·
Paolo Sorrentino
, Salvatore D’Angelo
, et al.
·
World Journal of Gastroenterology
·
44
PDF
Is immunotherapy in the future of therapeutic management of sarcomas?
2021
·
Ottavia Clemente
, Alessandro Ottaiano
, et al.
·
Journal of Translational Medicine
·
42
PDF
Response to Peptide Receptor Radionuclide Therapy in Pheocromocytomas and Paragangliomas: A Systematic Review and Meta-Analysis
2023
·
Antonella Lucia Marretta
, Alessandro Ottaiano
, et al.
·
Journal of Clinical Medicine
·
25
PDF
Validation of an extension of the international non‐invasive criteria for the diagnosis of hepatocellular carcinoma to the characterization of macroscopic portal vein thrombosis
2010
·
Paolo Sorrentino
, Luciano Tarantino
, et al.
·
Journal of Gastroenterology and Hepatology
·
23
The Management of Phaeochromocytomas and Paragangliomas in the Era of Precision Medicine: Where Are We Now? Evidence-Based Systemic Treatment Options and Future Cluster Oriented Perspectives
2024
·
Alessandra Bracigliano
, Antonella Lucia Marretta
, et al.
·
Pharmaceuticals
·
20
PDF
Selinexor and the Selective Inhibition of Nuclear Export: A New Perspective on the Treatment of Sarcomas and Other Solid and Non-Solid Tumors
2021
·
Antonella Lucia Marretta
, Giuseppe Di Lorenzo
, et al.
·
Pharmaceutics
·
12
PDF
Sentinel Lymph Node Detection by Lymphoscintigraphy in Malignant Melanoma
2002
·
MG Caprio
, G Carbone
, et al.
·
Tumori Journal
·
9
Enhancing patient-centered care with AI: a study of responses to neuroendocrine neoplasms queries
2025
·
Francesco Panzuto
, Alessandro Gallo
, et al.
·
Endocrine
·
8
FAP-α in soft tissue and bone sarcomas: A new potential diagnostic and therapeutic biomarker in the era of precision medicine
2025
·
Alessandra Bracigliano
, Ottavia Clemente
, et al.
·
Critical Reviews in Oncology/Hematology
·
6
The psychological impact of COVID‐19 pandemic on patients with neuroendocrine tumors: Between resilience and vulnerability
2021
·
Eleonora Lauricella
, Mauro Cives
, et al.
·
Journal of Neuroendocrinology
·
6
PDF
A new schedule of one week on/one week off temozolomide as second-line treatment of advanced neuroendocrine carcinomas (TENEC-TRIAL): a multicenter, open-label, single-arm, phase II trial
2024
·
C. von Arx
, G. Della Vittoria Scarpati
, et al.
·
ESMO Open
·
5
The Complex Management of the Breast Angiosarcoma: A Retrospective Study
2022
·
Lucia Cannella
, Francesco Perri
, et al.
·
Oncology
·
5
1200P A phase II single-arm interventional trial evaluating the activity and safety of CABOzantinib (CBZ) plus TEMozolomide (TMZ) in lung and gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) progressed after SSA therapy, everolimus, sunitinib or PRRT: CABOTEM Trial
2023
·
O. Clemente
, N. Starita
, et al.
·
Annals of Oncology
·
4
PDF
A systematic review and meta-analysis of pazopanib efficacy and adverse effects in sarcomas
2026
·
Fernanda Picozzi
, Alessandro Ottaiano
, et al.
·
Journal of Translational Medicine
·
2
Cabozantinib and temozolomide in patients with advanced progressive neuroendocrine tumors: a phase 2 study
2026
·
Mauro Cives
, Giuseppina Della Vittoria Scarpati
, et al.
·
Nature Communications
·
1
PDF
Additional file 1 of A systematic review and meta-analysis of pazopanib efficacy and adverse effects in sarcomas
2026
·
Picozzi, Fernanda
, Ottaiano, Alessandro
, et al.
·
Figshare
A systematic review and meta-analysis of pazopanib efficacy and adverse effects in sarcomas
2026
·
Picozzi, Fernanda
, Ottaiano, Alessandro
, et al.
·
Figshare
Additional file 2 of A systematic review and meta-analysis of pazopanib efficacy and adverse effects in sarcomas
2026
·
Picozzi, Fernanda
, Ottaiano, Alessandro
, et al.
·
Figshare
212P A phase II study of cabozantinib and temozolomide in advanced progressive gastroenteropancreatic or lung neuroendocrine tumors (NETs)
2024
·
O. Clemente
, M. Cives
, et al.
·
Annals of Oncology
PDF
Show more works
View as search
Works count:
31
Citation count:
770
H-index:
12
I10-index:
12
Year
Topic
Type